Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Caribou Biosciences (CRBU) Return on Capital Employed: 2021-2025

Historic Return on Capital Employed for Caribou Biosciences (CRBU) over the last 4 years, with Sep 2025 value amounting to -0.88%.

  • Caribou Biosciences' Return on Capital Employed fell 38.00% to -0.88% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.88%, marking a year-over-year decrease of 38.00%. This contributed to the annual value of -0.49% for FY2024, which is 18.00% down from last year.
  • As of Q3 2025, Caribou Biosciences' Return on Capital Employed stood at -0.88%, which was down 15.00% from -0.77% recorded in Q2 2025.
  • In the past 5 years, Caribou Biosciences' Return on Capital Employed registered a high of -0.16% during Q4 2021, and its lowest value of -0.88% during Q3 2025.
  • Its 3-year average for Return on Capital Employed is -0.49%, with a median of -0.39% in 2024.
  • As far as peak fluctuations go, Caribou Biosciences' Return on Capital Employed rose by 2bps in 2023, and later slumped by 38bps in 2025.
  • Caribou Biosciences' Return on Capital Employed (Quarterly) stood at -0.16% in 2021, then declined by 14bps to -0.30% in 2022, then rose by 2bps to -0.28% in 2023, then decreased by 28bps to -0.56% in 2024, then crashed by 38bps to -0.88% in 2025.
  • Its Return on Capital Employed was -0.88% in Q3 2025, compared to -0.77% in Q2 2025 and -0.62% in Q1 2025.